Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation (IMPACT-AF)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Bristol-Myers Squibb
Daiichi Sankyo Inc.
Boehringer Ingelheim
Bayer
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT02082548
First received: March 6, 2014
Last updated: September 26, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)